biomedicina slovenica


"Cardiotoxicity" : 40

  1. Jovanović Mark; Brvar Miran
    Toksični učinki kokaina na srčnožilni sistem in obravnava bolnikov z bolečino v prsih zaradi zlorabe kokaina
    [Toxic cardiovascular effects of cocaine and management of patients with cocaine- associated chest pain]
    2022
  2. Redenšek Trampuž Sara; Cvetkoska Aspasija; Dolžan Vita; Marinko Tanja; Goričar Katja
    Genetic variability and expression of miR-21 and miR-34a as biomarkers of cardiotoxicity after radiotherapy in breast cancer
    2022
  3. Podlesnikar Tomaž; Berlot Boštjan; Dolenc Jure; Goričar Katja; Marinko Tanja
    Radiotherapy-induced cardiotoxicity
    2022
  4. Harries Iwan; Berlot Boštjan; ffrench-Constant Natasha; Williams Matthew; Liang Kate; De Garate Estefania; Baritussio Anna; Biglino Giovanni; Plana Juan Carlos; Bucciarelli-Ducci Chiara
    Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction
    2021
  5. Geršak Blaž M.; Kukec Andreja; Steen Henning; Montenbruck Moritz; Šoštarič Maja
    Relationship between quality of life indicators and cardiac status indicators in chemotherapy patients
    [Povezanost med kazalniki kakovosti življenja ter kazalniki srčnega statusa pri bolnikih, ki prejemajo kemoterapijo]
    2021
  6. Byrne Julianne; Alessi Daniela; Allodji Rodrigue S.; Bagnasco Francesca; Bárdi Edit; Bautz Andrea; Bright Chloe J.; Diallo Ibrahima; Fidler Miranda M.; Zadravec-Zaletel Lorna
    The PanCareSurFup consortium
    2018
  7. Jezeršek Novaković Barbara; Boltežar Lučka; Novaković Aleksander
    Current opinion on pixantrone in the treatment of non-Hodgkin B-cell lymphoma
    2021
  8. Marinko Tanja; Stojanov Konda Jakob Timotej; Dolžan Vita; Goričar Katja
    Genetic variability of antioxidative mechanisms and cardiotoxicity after adjuvant radiotherapy in HER2-positive breast cancer patients
    2020
  9. Boltežar Lučka; Poglajen Gregor
    Srčno popuščanje in onkološko zdravljenje
    [Heart failure and oncologic treatment]
    2020
  10. Ratoša Ivica; Ivanetič Maja
    Cardiotoxicity of mediastinal radiotherapy
    2019
  11. Marinko Tanja
    Pericardial disease after breast cancer radiotherapy
    2019
  12. Seif Alix E.; Walker Dana; Li Yimei; Huang Yuan-Shun V.; Kavčič Marko; Torp Kari; Bagatell Rochelle; Fisher Brian T.; Aplenc Richard
    Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients
    2015
  13. Marinko Tanja; Borštnar Simona; Blagus Rok; Dolenc Jure; Bilban-Jakopin Cvetka
    Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
    2018
  14. Boltežar Lučka
    Cardiotoxicity and heart failure following oncologic treatment
    2017
  15. Omersa Daniel; Čufer Tanja; Marčun Robert; Lainščak Mitja
    Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    2017
  16. Matos Erika; Zakotnik Branko
    Ugotavljanje okvare srčne mišice pri bolnicah z rakom dojk na dopolnilnem zdravljenju s kemoterapijo in trastuzumabom
    2016
  17. Bober Peter; Alexovic Michal; Talian Ivan; Tomkova Zuzana; Viscorova Zuzana; Benckova Maria; Andrasina Igor; Ciccocioppo Rachele; Petrovič Danijel; Adamek Mariusz; Kruzliak Peter; Sabo Jan
    Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line
    2017
  18. Matos Erika; Jug Borut; Blagus Rok; Zakotnik Branko
    A prospective cohort study on cardiotoxicity of adjuvant trastuzumab therapy in breast cancer patients
    2016
  19. Marinko Tanja; Borštnar Simona; Blagus Rok; Dolenc Jure; Bilban-Jakopin Cvetka
    Effect of adjuvant concomitant treatment with radiotherapy and trastuzumab on cardiotoxicity in patients with breast cancer
    2015
  20. Matos Erika; Jug Borut; Zakotnik Branko
    Optimizing adherence to adjuvant trastuzumab therapy
    2014
  21. Marinko Tanja; Dolenc Jure; Bilban-Jakopin Cvetka
    Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
    2014
  22. Koželj Mirta; Zver Samo; Zadnik Vesna
    Long term follow-up report of cardiac toxicity in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    2013
  23. Letonja M; Petrovič D; Brvar M; Bunc M
    Cardiotoxicity in acute valporate poisoning
    2009
  24. Letonja Mitja; Petrovič Danijel
    Kardiotoksičnost in več-organska odpoved zaradi zastrupitve z valproatom
    [Cardiotoxicity and multiorgan system failure caused by valporate poisoning: case report and review of the literature]
    2009
  25. Letonja M; Petrovič D; Brvar M; Bunc M
    Cardiotoxicity in acute valproate poisoning
    2009
  26. Dolenc Jure; Koželj Mirta; Zver Samo
    Obravnava hematoloških bolnikov, zdravljenih s kardiotoksičnimi zdravili
    [Management of haematological pateints treated with cardiotoxic drugs]
    2008
  27. Injac Rade; Perše Martina; Bošković Marija; Djordjević Milić Vukosava; Djordjević Aleksandar; Hvala Anastazija; Cerar Anton; Štrukelj Borut
    Cardioprotective effects of fullerenol c60(oh)24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm
    2008
  28. Matos Erika; Čufer Tanja
    Adjuvant treatment of breast cancer patients with trastuzumab
    [Dopolnilno zdravljenje bolnic z rakom dojke s transtuzumabom]
    2007
  29. Zver Samo; Zadnik Vesna; Bunc Matjaž; Rogel Polona; Černelč Peter; Koželj Mirta
    Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    2007
  30. Zver Samo
    Kardiotoksičnost velikih odmerkov ciklofosfamida in melfalana pri zdravljenju bolnikov z diseminiranim plazmocitomom
    2007
  31. Miolo GianMaria; La Mura Nicoletta; Nigri Paola; Murrone Antonio; Da Ronch Laura; Viel Elda; Veronesi Andrea; Lestuzzi Chiara
    The cardiotoxicity of chemotherapy: new prospects for an old problem
    [Kardiotoksičnost kemoterapije. Nove rešitve starega problema]
    2006
  32. Piccart MJ; de Valeriola D; Dal-Lago L; de Azambuja E; Demonty G; Lebrun F; Bernard-Marty Ch; Colozza M; Čufer T
    Adjuvant chemotherapy in 2005: standards and beyond
    2005
  33. Bilban-Jakopin Cvetka; Zakotnik Branko
    Najpogostejše zdravstvene težave po radioterapiji in kemoterapiji
    [Most frequent side effects of radiotherapy and chemotherapy]
    2005
  34. Bunc Matjaž
    Učinki equinatoxina na gladko mišico koronarne arterije - možni vzroki kardiotoksičnosti
    1992
  35. Velenšek-Prestor Veronika; Rakovec Peter; Koželj Mirta; Jereb Berta
    Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood
    2000
  36. Zima T; Tesar V; Crkovska J; Stejskalova A; Teminova J; Nemeček K; Štipek S; Platenik J; Janebova M
    Cardioxane-ICFR-187 protects from adriamicyn-induced nephrotic syndome
    2000
  37. Velenšek-Prestor V; Koželj M; Jereb B
    Anthracycline-associated cardiotoxicity in long-term survivors of childhood leukemia
    1999
  38. Šuput D; Frangež R; Bunc M; Maček P; Turk T
    Cardiotoxicity of equinatoxin 2: mechanisms of decrease of coronary perfusion
    1995
  39. Bunc Matjaž; Drevenšek Gorazd; Budihna Metka; Šuput Dušan
    Effects of equinatoxin II from Actinia equina (L.) on isolated rat heart: the role of direct cardiotoxic effects in equinatoxin II lethality
    1999
  40. Budihna MV; Maček P; Šuput D
    Some possible mechanisms involved in the cardiotoxicity of equinatoxin II
    1992



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics